ImmunityBio stock today: IBRX slips in premarket as U.S.-Saudi biotech summit nears
New York, Jan 13, 2026, 05:42 (ET) — Premarket ImmunityBio shares were down 0.8% in premarket trading on Tuesday at $2.57, as of 5:00 a.m. ET. Around 13,000 shares had traded by that point, according to Public.com data. Premarket trading runs before the regular U.S. session opens at 9:30 a.m. ET and can be choppy. (Public) The biotech’s latest catalyst is a conference-week push into the spotlight. ImmunityBio and NantWorks on Monday announced an inaugural U.S.-Saudi Biotech Alliance Summit in San Francisco on Jan. 14, alongside the annual J.P. Morgan Healthcare Conference. “This initiative is about moving from strategy to